Brugada syndrome clinical update

References

• Brugada J, Campuzano O, Arbelo E, et al. Present status of Brugada syndrome: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(9):1046–1059.
   Web of Science ®Google Scholar
• Quan XQ, Li S, Liu R, et al. A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death. Med (United States). 2016. DOI:https://doi.org/10.1097/MD.0000000000005643
   Google Scholar
• Patel SS, Anees SS, Ferrick KJ. Prevalence of a Brugada pattern electrocardiogram in an urban population in the United States. Pacing Clin Electrophysiol. 2009;32(6):704–708.
   Web of Science ®Google Scholar
• Di Diego JM, Cordeiro JM, Goodrow RJ, et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 2002;106(15):2004–2011.
   PubMed Web of Science ®Google Scholar
• Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20(6):1391–1396.
   PubMed Web of Science ®Google Scholar
• Wilde AAM, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J. 2002. DOI:https://doi.org/10.1016/S0195-668X(02)93382-8.
   Google Scholar
• Bayés De Luna A, Brugada J, Baranchuk A, et al. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol. 2012;45(5):433–442.
   Web of Science ®Google Scholar
• Priori SG, Wilde AA, Horie M, et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. J Arrhythmia. 2014. DOI:https://doi.org/10.1016/j.joa.2013.08.001.
   Google Scholar
• Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2018. DOI:https://doi.org/10.1161/CIR.0000000000000549.
   Google Scholar
• Meregalli PG, Tan HL, Probst V, et al. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm. 2009;6(3):341–348.
   Web of Science ®Google Scholar
• Smits JPP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol. 2002;40(2):350–356.
   PubMed Web of Science ®Google Scholar
• Sumiyoshi M, Nakazato Y, Tokano T, et al. Sinus node dysfunction concomitant with Brugada syndrome. Circ J. 2005;69(8):946–950.
   Web of Science ®Google Scholar
• Francis J, Antzelevitch C. Atrial fibrillation and Brugada syndrome. J Am Coll Cardiol. 2008;51(12):1149–1153.
   Web of Science ®Google Scholar
• Nagase S, Hiramatsu S, Morita H, et al. Electroanatomical correlation of repolarization abnormalities in Brugada syndrome: detection of type 1 electrocardiogram in the right ventricular outflow tract. J Am Coll Cardiol. 2010;56(25):2143–2145.
   PubMed Web of Science ®Google Scholar
• Poli S, Toniolo M, Maiani M, et al. Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome. Europace. 2018;20(2):234–242.
   PubMed Web of Science ®Google Scholar
• Therasse D, Sacher F, Petit B, et al. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: safety and predictors of positivity. Heart Rhythm. 2017;14(10):1442–1448.
   PubMed Web of Science ®Google Scholar
• Chauveau S, Le Vavasseur O, Chevalier P. Delayed diagnosis of Brugada syndrome in a patient with aborted sudden cardiac death and initial negative flecainide challenge. Clin Case Rep. 2017;5(12):2022–2024.
   Web of Science ®Google Scholar
• Wolpert C, Echternach C, Veltmann C, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm. 2005;2(3):254–260.
   Web of Science ®Google Scholar
• Dubner S, Azocar D, Gallino S, et al. Single oral flecainide dose to unmask type 1 Brugada syndrome electrocardiographic pattern. Ann Noninvasive Electrocardiol. 2013;18(3):256–261.
   PubMed Web of Science ®Google Scholar
• Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020. DOI:https://doi.org/10.1016/j.hrthm.2019.03.002.
   Google Scholar
• Baranchuk A, Nguyen T, Ryu MH, et al. Brugada phenocopy: new terminology and proposed classification. Ann Noninvasive Electrocardiol. 2012;17(4):299–314.
   PubMed Web of Science ®Google Scholar
• Anselm DD, Baranchuk A. Terminological clarification of Brugada phenocopy, Brugada syndrome, and the Brugada ECG pattern: re. early repolarization pattern in patients with provocable Brugada phenocopy: a marker of additional arrhythmogenic cardiomyopathy. Int J Cardiol. 2014;171(2):288.
   PubMed Web of Science ®Google Scholar
• Ṕrez RAR, Uchida AH, Schapachnik E, et al. Propofol infusion syndrome and Brugada syndrome electrocardiographic phenocopy. Cardiol J. 2010.17(2):130-5.
   Web of Science ®Google Scholar
• Lukas A, Antzelevitch C. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. Cardiovasc Res. 1996;32(3):593–603.
   PubMed Web of Science ®Google Scholar
• Nishizaki M, Sakurada H, Ashikaga T, et al. Effects of glucose-induced insulin secretion on ST segment elevation in the Brugada syndrome. J Cardiovasc Electrophysiol. 2003;14(3):243–249.
   PubMed Web of Science ®Google Scholar
• Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392(6673):293–296.
   Web of Science ®Google Scholar
• Sarquella-Brugada G, Campuzano O, Arbelo E, et al. Brugada syndrome: clinical and genetic findings. Genet Med. 2016;18(1):3–12.
   PubMed Web of Science ®Google Scholar
• Probst V, Wilde AAM, Barc J, et al. SCN5A Mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet. 2009;2(6):552–557.
   PubMedGoogle Scholar
• Mizusawa Y, Wilde AAM. Brugada syndrome. Circ Arrhythmia Electrophysiol. 2012;5(3):606–616.
   PubMed Web of Science ®Google Scholar
• Frustaci A, Russo MA, Chimenti C. Structural myocardial abnormalities in asymptomatic family members with Brugada syndrome and SCN5A gene mutation. Eur Heart J. 2009;30(14):11763.
   Web of Science ®Google Scholar
• Catalano O, Antonaci S, Moro G, et al. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J. 2009;30(18):2241–2248.
   Web of Science ®Google Scholar
• Nademanee K, Raju H, De Noronha SV, et al. Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome. J Am Coll Cardiol. 2015;66(18):1976–1986.
   PubMed Web of Science ®Google Scholar
• Kabra N, Gupta R, Aronow WS, et al. Sudden cardiac death in Brugada syndrome. Cardiol Rev. 2020;28(4):203–207.
   PubMed Web of Science ®Google Scholar
• Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100(15):1660–1666.
   Web of Science ®Google Scholar
• Milman A, Andorin A, Gourraud JB, et al. Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: data from the survey on arrhythmic events in BRUgada Syndrome (SABRUS). Heart Rhythm. 2018. DOI:https://doi.org/10.1016/j.hrthm.2018.01.014.
   Google Scholar
• Casado-Arroyo R, Berne P, Rao JY, et al. Long-term trends in newly diagnosed Brugada syndrome: implications for risk stratification. J Am Coll Cardiol. 2016;68(6):614–623.
   PubMed Web of Science ®Google Scholar
• Takigawa M, Noda T, Shimizu W, et al. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm. 2008;5(11):1523–1527.
   PubMed Web of Science ®Google Scholar
• Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation. 1997;95(9):2277–2285.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27(5):1061–1070.
   PubMed Web of Science ®Google Scholar
• Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation. 2007;115(15):2042–2048.
   Web of Science ®Google Scholar
• Sieira J, Dendramis G, Brugada P. Pathogenesis and management of Brugada syndrome. Nat Rev Cardiol. 2016;13(12):744–756.
   PubMed Web of Science ®Google Scholar
• Shimizu W, Matsuo K, Kokubo Y, et al. Sex hormone and gender difference - Role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol. 2007;18(4):415–421.
   PubMed Web of Science ®Google Scholar
• Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2012;59(1):37–45.
   PubMed Web of Science ®Google Scholar
• Van Dijk N, Boer KR, Colman N, et al. High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the fainting assessment study. J Cardiovasc Electrophysiol. 2008;19(1):48–55.
   PubMed Web of Science ®Google Scholar
• Sieira J, Ciconte G, Conte G, et al. Asymptomatic Brugada syndrome: clinical characterization and long-term prognosis. Circ Arrhythmia Electrophysiol. 2015;8(5):1144–1150.
   Web of Science ®Google Scholar
• Gehi AK, Duong TD, Metz LD, et al. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol. 2006;17(6):577–583.
   PubMed Web of Science ®Google Scholar
• Sroubek J, Probst V, Mazzanti A, et al. Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis. Circulation. 2016;133(7):622–630.
   PubMed Web of Science ®Google Scholar
• Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with brugada syndrome: results from the finger Brugada syndrome registry. Circulation. 2010;121(5):635–643.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Akahoshi M, Seto S, et al. Disappearance of the Brugada-type electrocardiogram after surgical castration: a role for testosterone and an explanation for the male preponderance? Pacing Clin Electrophysiol. 2003;26(7p1):1551–1553.
   Google Scholar
• Mizusawa Y, Morita H, Adler A, et al. Prognostic significance of fever-induced Brugada syndrome. Heart Rhythm. 2016;13(7):1515–1520.
   PubMed Web of Science ®Google Scholar
• Chockalingam P, Rammeloo LA, Postema PG, et al. Fever-induced life-threatening arrhythmias in children harboring an SCN5A mutation. Pediatrics. 2011;127(1):e239-e244.
   PubMed Web of Science ®Google Scholar
• Sommariva E, Pappone C, Martinelli Boneschi F, et al. Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification. Eur J Hum Genet. 2013;21(9):911–917.
   PubMed Web of Science ®Google Scholar
• Sarkozy A, Sorgente A, Boussy T, et al. The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern. Eur Heart J. 2011;32(17):2153–2160.
   PubMed Web of Science ®Google Scholar
• Takagi M, Aonuma K, Sekiguchi Y, et al. The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan. Heart Rhythm. 2013;10(4):533–539.
   PubMed Web of Science ®Google Scholar
• Morita H, Kusano-Fukushima K, Nagase S, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol. 2002;40(8):1437–1444.
   PubMed Web of Science ®Google Scholar
• Kusano KF, Taniyama M, Nakamura K, et al. Atrial fibrillation in patients with Brugada syndrome. Relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol. 2008;51(12):1169–1175.
   Web of Science ®Google Scholar
• Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 2003;108(25):3092–3096.
   PubMed Web of Science ®Google Scholar
• Viskin S, Rogowski O. Asymptomatic Brugada syndrome: a cardiac ticking time-bomb? Europace. 2007;9(9):707–710.
   Web of Science ®Google Scholar
• Postema PG, Wolpert C, Amin AS, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm. 2009;6(9):1335–1341.
   Web of Science ®Google Scholar
• Xu YQ, Crumb WJ, Clarkson CW. Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. J Pharmacol Exp Ther. 1994;271(1):319–325.
   Web of Science ®Google Scholar
• Crumb WJ, Clarkson CW. Characterization of the sodium channel blocking properties of the major metabolites of cocaine in single cardiac myocytes. J Pharmacol Exp Ther. 1992;261(3):910–917.
   PubMed Web of Science ®Google Scholar
• Habuchi Y, Furukawa T, Tanaka H, et al. Ethanol inhibition of Ca2+ and Na+ currents in the guinea-pig heart. Eur J Pharmacol Environ Toxicol. 1995;292(2):143–149.
   PubMed Web of Science ®Google Scholar
• Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation. 2004;110(13):1731–1737.
   PubMed Web of Science ®Google Scholar
• Mizusawa Y, Sakurada H, Nishizaki M, et al. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment. J Cardiovasc Pharmacol. 2006;47(3):359–364.
   PubMed Web of Science ®Google Scholar
• Maury P, Hocini M, Haïssaguerre M. Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options. Indian Pacing Electrophysiol J. 2005;5(1):25–34.
   PubMedGoogle Scholar
• Patocskai B, Antzelevitch C. Novel therapeutic strategies for the management of ventricular arrhythmias associated with the Brugada syndrome. Expert Opin Orphan Drugs. 2015;3(6):633–651.
   PubMed Web of Science ®Google Scholar
• Shenthar J, Chakali SS, Acharya D, et al. Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy. Heart Rhythm Case Rep. 2017. DOI:https://doi.org/10.1016/j.hrcr.2017.07.005
   Google Scholar
• Mendes SL, Elvas L, Ramos D, et al. Fever in an elderly patient unmasks Brugada syndrome. Rev Port Cardiol. 2017;36(4):317–318.
   Google Scholar
• Viskin S, Wilde AAM, Guevara-Valdivia ME, et al. Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol. 2013;61(23):2383–2387.
   Web of Science ®Google Scholar
• Pappone C, Brugada J, Vicedomini G, et al. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythmia Electrophysiol. 2017;10(5). DOI:https://doi.org/10.1161/CIRCEP.117.005053
   Google Scholar
• Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123(12):1270–1279.
   PubMed Web of Science ®Google Scholar
• Brugada J, Pappone C, Berruezo A, et al. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythmia Electrophysiol. 2015;8(6):1373–1381.
   Web of Science ®Google Scholar